A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Uni Qure N.V. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 3,260 shares of QURE stock, worth $20,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,260
Previous 3,691 11.68%
Holding current value
$20,929
Previous $19,000 26.32%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$4.39 - $5.43 $1,892 - $2,340
-431 Reduced 11.68%
3,260 $14,000
Q1 2024

Apr 25, 2024

SELL
$4.82 - $6.93 $1,913 - $2,751
-397 Reduced 9.71%
3,691 $19,000
Q4 2023

Jan 30, 2024

SELL
$5.63 - $8.27 $52,443 - $77,035
-9,315 Reduced 69.5%
4,088 $27,000
Q3 2023

Oct 25, 2023

SELL
$6.71 - $11.83 $3,985 - $7,027
-594 Reduced 4.24%
13,403 $89,000
Q2 2023

Aug 07, 2023

BUY
$11.12 - $22.2 $21,828 - $43,578
1,963 Added 16.31%
13,997 $160,000
Q1 2023

May 08, 2023

SELL
$18.7 - $23.07 $149 - $184
-8 Reduced 0.07%
12,034 $242,000
Q4 2022

Feb 01, 2023

BUY
$18.12 - $27.32 $23,374 - $35,242
1,290 Added 12.0%
12,042 $272,000
Q3 2022

Nov 09, 2022

SELL
$16.98 - $25.54 $51,279 - $77,130
-3,020 Reduced 21.93%
10,752 $202,000
Q2 2022

Aug 09, 2022

SELL
$13.15 - $20.45 $5,378 - $8,364
-409 Reduced 2.88%
13,772 $257,000
Q1 2022

Apr 21, 2022

SELL
$14.54 - $21.5 $843 - $1,247
-58 Reduced 0.41%
14,181 $256,000
Q4 2021

Feb 01, 2022

BUY
$20.24 - $36.01 $63,735 - $113,395
3,149 Added 28.39%
14,239 $295,000
Q3 2021

Nov 15, 2021

SELL
$26.01 - $38.22 $3,407 - $5,006
-131 Reduced 1.17%
11,090 $355,000
Q2 2021

Jul 30, 2021

SELL
$29.97 - $37.17 $21,188 - $26,279
-707 Reduced 5.93%
11,221 $346,000
Q1 2021

May 03, 2021

BUY
$29.24 - $42.03 $156,170 - $224,482
5,341 Added 81.08%
11,928 $402,000
Q2 2020

Jul 28, 2020

BUY
$45.06 - $67.74 $46,997 - $70,652
1,043 Added 18.81%
6,587 $297,000
Q4 2019

Jan 21, 2020

BUY
$37.13 - $74.62 $132,516 - $266,318
3,569 Added 180.71%
5,544 $397,000
Q3 2019

Oct 18, 2019

BUY
$39.36 - $76.8 $13,618 - $26,572
346 Added 21.24%
1,975 $78,000
Q1 2019

Apr 29, 2019

SELL
$27.39 - $68.41 $14,461 - $36,120
-528 Reduced 24.48%
1,629 $97,000
Q2 2018

Aug 06, 2018

BUY
$21.96 - $39.94 $47,367 - $86,150
2,157 New
2,157 $82,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.